Low prevalence of hepatitis C infection in hepatocellular carcinoma (HCC) cases and population controls in Guangxi, a hyperendemic region for HCC in the People's Republic of China
1996

Low Prevalence of Hepatitis C in Liver Cancer Cases in Guangxi, China

Sample size: 141 publication Evidence: moderate

Author Information

Author(s): J-M Yuan, S Govindarajan, BE Henderson, MC Yu

Primary Institution: University of Southern California School of Medicine

Hypothesis

Is hepatitis C infection a significant risk factor for hepatocellular carcinoma in Guangxi, a region with high liver cancer rates?

Conclusion

Hepatitis C infection is not a significant environmental determinant of hepatocellular carcinoma risk in southern Guangxi.

Supporting Evidence

  • Only one of 141 control subjects tested positive for hepatitis C.
  • None of the 39 HCC cases tested positive for hepatitis C.
  • The findings are consistent with previous studies showing low hepatitis C rates in HCC cases in Guangxi.

Takeaway

In Guangxi, very few people with liver cancer have hepatitis C, which means it likely doesn't cause liver cancer there.

Methodology

Serum samples from 39 HCC cases and 41 controls were tested for hepatitis C antibodies using ELISA and confirmed with RIBA.

Potential Biases

Potential bias due to the reliance on serological tests that may have varying accuracy.

Limitations

The study was limited by the small number of HCC cases and controls tested.

Participant Demographics

Participants included 39 HCC patients and 41 controls, primarily male, with a mean age around 44 years.

Statistical Information

Confidence Interval

0.7% (upper 95% confidence limit, 3.2%) for controls; 0% (upper 95% confidence limit, 6.1%) for HCC cases.

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication